Literature DB >> 23551745

Assessing the use of haemostatic sealants in tubeless percutaneous renal access and their effect on renal drainage and histology: an experimental porcine study.

Christos Rigopoulos1, Iason Kyriazis, Panagiotis Kallidonis, Christina Kalogeropoulou, Dimitra Koumoundourou, Ioannis Georgiopoulos, Theodore Petsas, Dimitrios Karnabatidis, Costantinos Constantinides, Evangelos Liatsikos.   

Abstract

OBJECTIVE: To evaluate the mid-term effects of haemostatic sealant application during tubeless percutaneous nephrolithotomy (PCNL) on renal drainage and histology in an in vivo porcine study.
MATERIALS AND METHODS: Bilateral percutaneous access was established in 28 porcine renal units. At the end of the procedure, a type 1 absorbable fish origin collagen powder, a human fibrinogen- and thrombin-coated sponge or a cross-linked gelatin granule/topical thrombin matrix were randomly placed on the nephrostomy tracts. Four nephrostomy accesses were left intact and served as controls. No percutaneous tube, ureteric stent or bladder catheter was left in place postoperatively. Computed tomography urography on postoperative days 1, 15, 30 and 40 was used to access renal drainage. On postoperative day 40, all animals were killed and both kidneys from each animal were harvested for histological evaluation.
RESULTS: Evidence of risk for drainage occlusion after sealant application was found. The use of haemostatic sealants was associated with significant histological lesions in the renal parenchyma, regardless of which sealant was used. No sealant was identified as superior to the others. Nephrostomy tracts that were left without sealant application (control group) were associated with no morbidity and fewer histopathological changes.
CONCLUSIONS: Based on these experimental results, the safety of the application of haemostatic sealants in tubeless PCNL should be reassessed, focusing not only on the potential of such materials to occlude urinary drainage but also on their effect on renal histology. Further investigation is considered necessary.
© 2013 BJU International.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551745     DOI: 10.1111/bju.12060

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

Review 1.  The management of the access tract after percutaneous nephrolithotomy.

Authors:  Tanja Hüsch; Michael Reiter; René Mager; Eva Steiner; Thomas R W Herrmann; Axel Haferkamp; David Schilling
Journal:  World J Urol       Date:  2015-04-23       Impact factor: 4.226

2.  Tubeless percutaneous nephrolithotomy with non-absorbable hemostatic sealant (Quikclot®) versus nephrostomy tube placement: a propensity score-matched analysis.

Authors:  Kyo Chul Koo; Sang Un Park; Ho Sung Jang; Chang-Hee Hong
Journal:  Urolithiasis       Date:  2015-06-30       Impact factor: 3.436

Review 3.  Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis.

Authors:  Cui Yu; Zhou Xu; Wang Long; Liu Longfei; Zeng Feng; Qi Lin; Zu Xiongbing; Chen Hequn
Journal:  Urolithiasis       Date:  2014-07-27       Impact factor: 3.436

4.  The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy: a meta-analysis.

Authors:  Jiawu Wang; Chengyao Zhang; Guangzhong Tan; Bo Yang; Wenkai Chen; Dan Tan
Journal:  Urolithiasis       Date:  2014-09-09       Impact factor: 3.436

5.  Does topical hemostatic agent (Floseal®) have a long-term adverse effect on erectile function recovery after nerve-sparing robot-assisted radical prostatectomy?

Authors:  Eugenio Martorana; Bernardo Rocco; Shaniko Kaleci; Giacomo Maria Pirola; Luigi Bevilacqua; Luca Reggiani Bonetti; Stefano Puliatti; Salvatore Micali; Giampaolo Bianchi
Journal:  Int Urol Nephrol       Date:  2017-07-04       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.